Related Experiment Video
Updated: Oct 22, 2025
Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain
Published on: January 4, 2018
Increased Hypothalamic Anti-Inflammatory Mediators in Non-Diabetic Insulin Receptor Substrate 2-Deficient Mice
María Vinaixa1,2, Sandra Canelles3,4, África González-Murillo5
1Metabolomics Platform, IISPV, Department of Electronic Engineering (DEEEA), Universitat Rovira i Virgili, E-43002 Tarragona, Spain.
Abstract:
Insulin receptor substrate (IRS) 2 is a key mediator of insulin signaling and IRS-2 knockout (IRS2-/-) mice are a preclinical model to study the development of diabetes, as they develop peripheral insulin resistance and beta-cell failure. The differential inflammatory profile and insulin signaling in the hypothalamus of non-diabetic (ND) and diabetic (D) IRS2-/- mice might be implicated in the onset of diabetes. Because the lipid profile is related to changes in inflammation and insulin sensitivity, we analyzed whether ND IRS2-/- mice presented a different hypothalamic fatty acid metabolism and lipid pattern than D IRS2-/- mice and the relationship with inflammation and markers of insulin sensitivity. ND IRS2-/- mice showed elevated hypothalamic anti-inflammatory cytokines, while D IRS2-/- mice displayed a proinflammatory profile. The increased activity of enzymes related to the pentose-phosphate route and lipid anabolism and elevated polyunsaturated fatty acid levels were found in the hypothalamus of ND IRS2-/- mice. Conversely, D IRS2-/- mice have no changes in fatty acid composition, but hypothalamic energy balance and markers related to anti-inflammatory and insulin-sensitizing properties were reduced. The data suggest that the concurrence of an anti-inflammatory profile, increased insulin sensitivity and polyunsaturated fatty acids content in the hypothalamus may slow down or delay the onset of diabetes.
Insights
Non-diabetic Insulin Receptor Substrate-2 knockout mice show enhanced hypothalamic fatty acid metabolism and anti-inflammatory markers, potentially delaying diabetes onset. Diabetic mice exhibit a proinflammatory profile and reduced insulin sensitivity.
Area of Science:
- Metabolic Research
- Neuroendocrinology
- Diabetes Pathophysiology
Background:
- Insulin receptor substrate (IRS)-2 is crucial for insulin signaling.
- IRS-2 knockout mice serve as a model for diabetes development, exhibiting insulin resistance and beta-cell failure.
- Hypothalamic inflammation and insulin signaling may influence diabetes onset.
Purpose of the Study:
- To investigate hypothalamic fatty acid metabolism and lipid profiles in non-diabetic (ND) versus diabetic (D) IRS-2 knockout mice.
- To explore the relationship between lipid profiles, inflammation, and insulin sensitivity in the hypothalamus.
- To understand how hypothalamic changes contribute to the development of diabetes in IRS2-/- mice.
Main Methods:
- Comparative analysis of hypothalamic lipid profiles and fatty acid metabolism between ND and D IRS2-/- mice.
- Assessment of inflammatory cytokine profiles (anti-inflammatory vs. proinflammatory).
- Evaluation of enzymes involved in the pentose-phosphate pathway and lipid anabolism.
Main Results:
- ND IRS2-/- mice displayed elevated anti-inflammatory cytokines and increased polyunsaturated fatty acids in the hypothalamus.
- D IRS2-/- mice exhibited a proinflammatory hypothalamic profile with no significant changes in fatty acid composition.
- Reduced hypothalamic energy balance and insulin-sensitizing markers were observed in D IRS2-/- mice.
Conclusions:
- An anti-inflammatory hypothalamic environment, coupled with increased polyunsaturated fatty acids and insulin sensitivity, may delay diabetes onset in IRS2-/- mice.
- Dysregulation of hypothalamic lipid metabolism and inflammation are implicated in the progression to diabetes.
- Targeting hypothalamic pathways could offer strategies for diabetes prevention or management.
